These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37743402)

  • 1. Association of mismatch repair deficiency in endometrial cancer with
    Sun X; Yao X; Zeng B; Zhu L; Shang Y; Zhang Q; He L; Jiang L
    Ann Nucl Med; 2023 Dec; 37(12):655-664. PubMed ID: 37743402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic characteristics and outcomes of endometrial Cancer patients with mismatch repair deficiency in the era of universal Lynch syndrome screening.
    Carr C; Son J; Yao M; Priyadarshini A; Marquard J; Vargas R; Michener C; AlHilli MM
    Gynecol Oncol; 2020 Dec; 159(3):712-720. PubMed ID: 33046272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endometrial Cancer Presentation and Outcomes Based on Mismatch Repair Protein Expression From a Population-Based Study.
    Pina A; Wolber R; McAlpine JN; Gilks B; Kwon JS
    Int J Gynecol Cancer; 2018 Oct; 28(8):1624-1630. PubMed ID: 30095707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mismatch repair status in high-grade endometrial carcinomas of endometrioid and non-endometrioid type.
    Doulgeraki T; Vagios S; Kavoura E; Yiannou P; Messini I; Nonni A; Papadimitriou C; Vlachos A; Pavlakis K
    J BUON; 2019; 24(5):2020-2027. PubMed ID: 31786870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of mismatch repair deficiency in high- and low-intermediate-risk, early-stage endometrial cancer following vaginal brachytherapy.
    Li JY; Park HS; Huang GS; Young MR; Ratner E; Santin A; Damast S
    Gynecol Oncol; 2021 Dec; 163(3):557-562. PubMed ID: 34602287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of metabolic tumor volume and total lesion glycolysis from ¹⁸F-FDG PET/CT in lymph node metastases and risk stratification of endometrial carcinoma.
    Liu DD; Li J; Li X; Xie L; Qin L; Peng F; Cheng MH
    J Gynecol Oncol; 2019 Nov; 30(6):e89. PubMed ID: 31576685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of single agent PD-1 or PD-L1 inhibition on advanced endometrial cancers: meta-analysis.
    Kok PS; Antill YC; Scott CL; Lee CK
    ESMO Open; 2022 Dec; 7(6):100635. PubMed ID: 36410086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive Clinicopathologic Analysis for Mismatch Repair Protein Expression in Unselected Endometrial Carcinoma Patients With an Emphasis on the Role of MLH1 Deficiency.
    Huang SW; Lin H; Huang CC; Ou YC; Fu HC; Tsai CC; Changchien CC; Wu CH
    Int J Gynecol Pathol; 2022 Jul; 41(4):407-416. PubMed ID: 34347667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic Tumor Volume on 18F-FDG PET/CT Improves Preoperative Identification of High-Risk Endometrial Carcinoma Patients.
    Husby JA; Reitan BC; Biermann M; Trovik J; Bjørge L; Magnussen IJ; Salvesen ØO; Salvesen HB; Haldorsen IS
    J Nucl Med; 2015 Aug; 56(8):1191-8. PubMed ID: 26045311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Association of status of mismatch repair protein expression and EB virus infection with clinicopathological parameters in 886 gastric adenocarcinoma patients].
    Liu Y; Zang FL; Qiu ZQ; Guo YH; Luo Y; Sun L; Zhao S; Shao B; Liang H; Sun Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 May; 24(5):440-448. PubMed ID: 34000774
    [No Abstract]   [Full Text] [Related]  

  • 11. A retrospective study of consistency between immunohistochemistry and polymerase chain reaction of microsatellite instability in endometrial cancer.
    Wang C; Kuang W; Zeng J; Ren Y; Liu Q; Sun H; Feng M; Liang D
    PeerJ; 2023; 11():e15920. PubMed ID: 37663290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET Parameters are Useful in Predicting Endometrial Cancer Risk Classes and Prognosis.
    Budak A; Beyan E; Inan AH; Kanmaz AG; Aldemir OS; Oral A; Yazici B; Akgün A; Ozeren M
    Nuklearmedizin; 2021 Feb; 60(1):16-24. PubMed ID: 33105511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic significance of mismatch repair protein expression in endometrioid endometrial cancer.
    Kim MK; So KA; Chun YK; Kim YH; Lim KT; Lee KH; Kim TJ
    Taiwan J Obstet Gynecol; 2023 Sep; 62(5):724-728. PubMed ID: 37679002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and prognostic value of
    Albano D; Zizioli V; Odicino F; Giubbini R; Bertagna F
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(2):87-93. PubMed ID: 30573388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of metabolic parameters of primary lesions examined by 18F-FDG PET/CT for endometrial cancer in preoperative evaluation.
    Gai QZ; Lv YB; Li GY; Zhang DQ; Gao Z; Fang XH
    Eur Rev Med Pharmacol Sci; 2021 Mar; 25(6):2493-2502. PubMed ID: 33829435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Value of 16α-
    Yamada S; Tsuyoshi H; Yamamoto M; Tsujikawa T; Kiyono Y; Okazawa H; Yoshida Y
    J Nucl Med; 2021 May; 62(5):636-642. PubMed ID: 33008930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative 18F-Fluorodeoxyglucose Positron Emission Tomography/CT in Prediction of Uterine Risk Factors and Lymph Node Metastasis: An Analysis of 111 Endometrioid Endometrial Cancer Patients.
    Konuralp Atakul B; Taşkın S; Soydal Ç; Sükür YE; Kahraman A; Koyuncu K; İbiş E; Ortac F
    Gynecol Obstet Invest; 2017; 82(4):340-348. PubMed ID: 27771729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic role of FDG PET-derived parameters in preoperative staging of endometrial cancer.
    Mapelli P; Bergamini A; Fallanca F; Rancoita PMV; Cioffi R; Incerti E; Rabaiotti E; Petrone M; Mangili G; Candiani M; Gianolli L; Picchio M
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(1):3-9. PubMed ID: 30573387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of association between deficient mismatch repair expression and outcome in endometrial carcinomas of the endometrioid type.
    Ruiz I; Martín-Arruti M; Lopez-Lopez E; Garcia-Orad A
    Gynecol Oncol; 2014 Jul; 134(1):20-3. PubMed ID: 24814467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-FDG PET/CT findings in endometrial cancer patients: the correlation between SUVmax and clinicopathologic features.
    Boonya-ussadorn T; Choi WH; Hyun J; Kim SH; Chung SK; Yoo IeR
    J Med Assoc Thai; 2014 Feb; 97 Suppl 2():S115-22. PubMed ID: 25518184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.